Plain English Breakdown
The official source material does not provide specific details on cost implications for health care plans and insurers, only that no reimbursement from local agencies or school districts is required.
Health Care Coverage for Dementia
The bill requires health care plans and insurance policies to cover medically necessary treatments and medications approved by the FDA for Alzheimer's disease or other related dementias, starting in 2027.
What This Bill Does
- Requires health care service plan contracts and health insurance policies issued, amended, or renewed after January 1, 2027, to include coverage for all medically necessary treatments or medications approved by the FDA for Alzheimer's disease or other related dementias.
- Does not require plans to cover multiple versions of the same drug if they are pharmaceutically equivalent and approved by the FDA.
- Prohibits health insurers from requiring patients to try other drugs before getting a specific treatment for Alzheimer’s or related dementias, except as provided.
- Requires health care service plans that cover nonself-administered treatments for dementia to also include them as outpatient prescription benefits.
Who It Names or Affects
- People with health insurance who have been diagnosed with Alzheimer's disease or other types of dementia.
- Health care service plans and health insurers in California.
Terms To Know
- FDA
- The United States Food and Drug Administration, which approves medications and treatments for safety and effectiveness.
- Step therapy protocols
- A process where patients must try one or more drugs before getting a specific treatment their doctor recommends.
Limits and Unknowns
- The bill does not specify what happens if the FDA approves multiple versions of the same drug.
- It is unclear how much this will cost health care plans and insurers, but it states that no reimbursement from local agencies or school districts is required for this act.